Application | Comment | Organism |
---|---|---|
medicine | calpain-6 is a therapeutic target in chemoresistant osteosarcoma | Homo sapiens |
medicine | calpain-6 is a possible therapeutic target in chemoresistant osteosarcoma | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
143B cell | - |
Homo sapiens | - |
bone | - |
Homo sapiens | - |
bone marrow | - |
Homo sapiens | - |
MG-63 cell | - |
Homo sapiens | - |
MNNG/HOS cell | - |
Homo sapiens | - |
osteosarcoma cell | - |
Homo sapiens | - |
SAOS-2 cell | - |
Homo sapiens | - |
U2-OS cell | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
calpain-6 | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | calpain-6 is a target gene downregulated by syndecan-2 in cells and in vivo. Syndecan-2 decreases calpain-6 expression by inhibiting endothelin-1-induced signaling | down |
Homo sapiens | calpain-6 expression in osteosarcoma cells depends on endothelin-1. Calpain-6 is increased by doxorubicin (10 ng/ml) and expressed at higher levels in doxorubicin-resistant U2OS osteosarcoma-derived cells as compared to responsive cells | up |
Homo sapiens | calpain-6 expression depends on NFkappaB activity and endothelin-1. Calpain-6 expression is increased by doxorubicin | up |
General Information | Comment | Organism |
---|---|---|
malfunction | inhibition of calpain-6 with shRNA results in decreased proliferation, increased spontaneous apoptosis and increased sensitivity to doxorubicin and also methotrexate in responsive and resistant osteosarcoma cells | Homo sapiens |
metabolism | the enzyme capain-6 is negatively controlled by the proteoglycan syndecan-2, that controls the activity of various cytokines and growth factors and also modulates apoptosis and response to cytotoxic agents in osteosarcoma cell lines. Syndecan-2 exerts its pro-apoptotic function through modulation of the endothelin-1/NFkappaB signaling and through downregulation of calpain-6. Calpain-6 expression in osteosarcoma cells depends on endothelin-1, a mediator of the tumor progression in bone. Syndecan-2 overexpression alters ERK1/2, PI3K/AKT and NFjB pathways that are calpain-6-promoting signals downstream of endothelin-1 | Homo sapiens |
physiological function | calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma | Homo sapiens |
physiological function | calpain-6 is a protective factor that contributes to abnormal cell survival | Homo sapiens |